drugset
Drugs / 11β-methyl-nortestosterone-dodecylcarbonate
last change Feb 2020 re-read 3 minutes ago

11β-methyl-nortestosterone-dodecylcarbonate

also known as 11β-MNTDC
Investigated by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Premier Research · University of Washington

Trials 1

today NCT03298373 · Ph 1
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03298373 Nov 2017 → Feb 2019 — Premier Research Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 11β-methyl-nortestosterone-dodecylcarbonate ClinicalTrials.gov intervention name — accepted as the source's own label NCT03298373 ↗
Known as 11β-MNTDC “11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC)” NCT03298373 ↗
Route Oral “administered in 200 mg or 400 mg doses orally” NCT03298373 ↗